The treatment landscape for International Lambert-Eaton Myasthenic Syndrome (LEMS) is in a state of flux. While there is no cure at this time, a variety of treatment options are available to manage symptoms and improve quality of life. Popular therapies include corticosteroids, aimed at regulating the autoimmune response. In lately, there has been